Finance
Results: 9397-9408 of 48768

AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis

Stena RoRo takes delivery of the 13th E-Flexer from the China Merchants Industry shipyard in Weihai, China

Angelalign Technology (6699.HK) Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth






